Stucker Fabien, Ponte Belen, De la Fuente Victoria, Alves Cyrielle, Rutschmann Olivier, Carballo Sebastian, Vuilleumier Nicolas, Martin Pierre-Yves, Perneger Thomas, Saudan Patrick
Nephrology Unit, Hôpital de la Providence, Neuchâtel, Switzerland.
Nephrology Unit, Department of Medical Specialties, Geneva University Hospitals, 4 rue Gabrielle Perret-Gentil, 1211, Geneva, Switzerland.
BMC Nephrol. 2017 Dec 29;18(1):380. doi: 10.1186/s12882-017-0792-2.
We aimed to describe clinical characteristics of patients with community-acquired acute kidney injury (CA-AKI), the effectiveness of initial management of CA-AKI, its prognosis and the impact of medication on its occurrence in patients with previous chronic kidney injury (CKI).
We undertook a prospective observational study within the Emergency Department (ED) of a University Hospital, screening for any patient >16 years admitted with an eGFR <60 ml/mn/1.73 m and a rise in serum creatinine as compared to previous values. Patients' medical files were reviewed by a panel of nephrologists in the subsequent days and at one and three-years follow-up.
From May 1st to June 21st 2013, there were 8464 admissions in the ED, of which 653 had an eGFR <60 ml/mn/1.73 m. Of these, 352 had previous CKI, 341 had CA-AKI, and 104 had CA-ACKI (community-acquired acute on chronic kidney injury). Occurrence of superimposed CA-AKI in CKI patients was associated with male gender and with use of diuretics, but not with use of ARBs or ACEIs. Adequate management of CA-AKI defined as identification, diagnostic procedures and therapeutic intervention within 24 h, was recorded in 45% of the cases and was not associated with improved outcomes. Three-year mortality was 21 and 48% in CKI and CA-ACKI patients respectively, and 40% in patients with only CA-AKI (p < 0.001). Mortality was significantly associated with age, hypertension, ischemic heart disease and CA-AKI. Progression of renal insufficiency was associated with male gender and age.
CA-AKI is more frequently encountered in male patients and those treated with diuretics and is an independent risk factor for long-term mortality. Its initial adequate management failed to improve outcomes.
我们旨在描述社区获得性急性肾损伤(CA-AKI)患者的临床特征、CA-AKI初始治疗的有效性、其预后以及药物治疗对既往慢性肾损伤(CKI)患者发生CA-AKI的影响。
我们在一家大学医院的急诊科进行了一项前瞻性观察研究,筛查年龄>16岁、入院时估算肾小球滤过率(eGFR)<60ml/分钟/1.73平方米且血清肌酐较之前值升高的患者。随后几天以及在1年和3年随访时,由一组肾病专家对患者的病历进行审查。
2013年5月1日至6月21日,急诊科共收治8464例患者,其中653例eGFR<60ml/分钟/1.73平方米。其中,352例有既往CKI,341例发生CA-AKI,104例发生社区获得性急性慢性肾损伤(CA-ACKI)。CKI患者叠加发生CA-AKI与男性性别以及使用利尿剂有关,但与使用血管紧张素受体阻滞剂(ARBs)或血管紧张素转换酶抑制剂(ACEIs)无关。45%的病例记录了对CA-AKI的充分管理,定义为在24小时内进行识别、诊断程序和治疗干预,且这与改善预后无关。CKI和CA-ACKI患者的3年死亡率分别为21%和48%,仅CA-AKI患者的死亡率为40%(p<0.001)。死亡率与年龄、高血压、缺血性心脏病和CA-AKI显著相关。肾功能不全的进展与男性性别和年龄有关。
CA-AKI在男性患者和使用利尿剂治疗的患者中更常见,并且是长期死亡率的独立危险因素。其初始的充分管理未能改善预后。